ANOVA PANCAN result package
Francesco Iorio, EMBL - European Bioinformatics Institute
result parsing started on 2016-03-31 19:01:06 iorio@ebi.ac.uk
Drug Domain: GDSC1000_paper_set, Analysis Domain: panCancer
Individual drug analysis: 1371
Drug details and screening numbers
Drug Name: PLX4720 (rescreen)
Drug ID: 1371
Synonyms: Vemurafenib (derivative)
Brand name: Zelboraf
Target: BRAF
Number of cell lines screened: 918
Screening concentration range(s): 0.0390625 to 10 uM
Statistically significant associations identified = 1
association id |
FEATURE |
Drug id |
Propr |
Public |
Drug Name |
Drug Target |
N FEATURE pos |
N FEATURE neg |
log max Conc tested |
FEATURE neg logIC50 MEAN |
FEATURE pos logIC50 MEAN |
FEATURE deltaMEAN IC50 |
FEATURE IC50 effectSize |
FEATURE neg Glass delta |
FEATURE pos Glass delta |
ANOVA FEATURE pval |
Tissue ANOVA pval |
MSI ANOVA pval |
ANOVA FEATURE FDR % |
a4 |
BRAF_mut |
1371 |
1 |
1 |
PLX4720 (rescreen) |
BRAF |
81 |
834 |
2.3 |
4.18 |
2.06 |
-2.12 |
2 ** |
2.2 ** |
1.2 * |
1.17e-29 |
3.79e-58 |
1.52e-01 |
4.8e-23 |
All-tests volcano plot